- Sorted by date
- Hybrid Sort
- Smart Random Sort
- Sort by relevance
Advertisements
» Related Searches: cancer, breast cancer, prostate cancer, cancer patients, lung cancer treatment
Results 41 to 50 of 68 
NICE consults on advice on two treatments for NSCLC
The National Institute for Health and Clinical Excellence has issued appraisal
consultation documents on Tarceva (erlotinib) and Alimat (pemetrexed) for the treatment of
non-small-cell lung cancer, recommending neither drug … 
- ├ US national Gwendolyn Sarah Melich (R) consults … — Health Photos - AFP on Yahoo! News Photos
- ├ Targeting Symptoms With Targeted Agents in NSCLC: … — Medscape Pulmonary Medicine Headlines
- ├ Nurture Mind, Body and Soul with New … — DBusiness News - San Francisco
- └ all 10 related »
Watchdog rules against new treatment for lung cancer
Thousands of lung cancer sufferers are set to be denied the drug Tarceva, under
draft guidance from health watchdog …
- ├ ENGLAND WON'T GET LUNG DRUG — Mirror.co.uk - 3am - 3am Content
- ├ Lung cancer top killer among malignant tumors … — KeralaNext: China
- ├ Nab-Paclitaxel and Carboplatin Appear Effective in Lung … — Medscape Hematology-Oncology Headlines
- └ all 10 related »
ENGLAND WON'T GET LUNG DRUG
LUNG cancer sufferers in England are to be denied a drug which is freely
available in Scotland, a health watchdog decided yesterday …
- ├ Cancer drug guidance dismay — BBC News | UK News | England | World Edition
- ├ Cancer drug guidance concern — BBC News | Health | UK Edition
- ├ Dismay over cancer drug guidance — BBC News | Latest Published Stories | UK Edition
- └ all 10 related »
Reata brain cancer therapy shows strong activity
Reata Pharmaceuticals has reported interim results from its ongoing phase I trial of RTA
744 in advanced primary brain tumors that showed evidence of strong drug activity …
- ├ Adding Bevacizumab to First-Line Lung Cancer Therapy … — Medscape Headlines
- ├ Recurrent breast cancer: Drug shows promise — The Cancer Blog
- ├ U-M researchers use nanoparticles to target brain … — EurekAlert! - Cancer
- └ all 10 related »
Aeterna prostate cancer drug shows promise
Aeterna Zentaris has presented detailed positive phase II results in hormone-dependent,
inoperable prostate cancer for its compound ozarelix …
- ├ Dendreon completes FDA filing for prostate-cancer drug … — The Seattle Times: Horse racing
- ├ A transmission electron micrograph shows a prostate … — Top Stories Photos - Reuters on Yahoo! News Photos
- ├ Anti-cancer drug shows early promise in pulmonary … — EurekAlert! - Breaking News
- └ all 10 related »
NHS bar on lung cancer treatment
An innovative cancer drug has been turned down for use on the NHS, shortening the
lives of thousands of people who could benefit from it …
- ├ New Treatment Finds Success, Long Survival In … — Health News from Medical News Today
- ├ NICE disapproves the use of cancer drug Tarceva — The Earth Times Online Newspaper
- ├ Roswell signs for lung cancer registry — Latest news from Business First of Buffalo
- └ all 10 related »
Cancer drug guidance concern
Campaigners express dismay that a lung cancer drug available in Scotland may not be
approved for England …
- ├ NICE rejects use of cancer drug Tarceva — Pharmaceutical Business Review Latest News
- ├ NICE refuses to fund £20,000 cancer drug … — the Mail online | Home
- ├ NICE refuse to fund life-prolonging cancer drug … — the Mail online | Health
- └ all 10 related »
Anti-Cancer Tinker Toys
Cancer research has taken a couple of major steps forward recently.Cancer cells
need to be located, scanned, and killed. By putting several different functions into a
single large molecule, part …
- ├ Patients Respond Well To First Study To … — Health News from Medical News Today
- ├ Patients Respond Well To Higher Doses Of … — Health News from Medical News Today
- ├ **FILE PHOTO** Lance Cpl. Rasheed Baloquin passes … — U.S. Military on Yahoo! News Photos
- └ all 10 related »
Southern Research CEO Jack Secrist Recognized for Contributions in Cancer …
Receives the 2006 John A. Montgomery Award in Switzerland …
- ├ SRI's Jack Secrist receives award in Switzerland … — Latest news from Birmingham Business Journal
- ├ First Berlin Releases Research Update Following Callisto … — Health News from Medical News Today
- ├ Ludwig Fund donates $20 million to University … — EurekAlert! - Chemistry, Physics and Materials Sciences …
- └ all 10 related »
NICE refuses to fund £20,000 cancer drug available in Scotland
Thousands of cancer patients are set to be denied a life-prolonging drug on the
NHS - even though it is available in Scotland. In yet another example of so-called medical
'apartheid' …
- ├ NICE refuses to fund life-prolonging cancer drug … — the Mail online | Health
- ├ MIT receives Ludwig Fund cancer grant — United Press International - NewsTrack
- └ all 10 related »